Akèy › Depresyon › Connecticut
Etid klinik pou Depresyon nan Connecticut
15 etid pou Depresyon ap chèche patisipan nan sit nan Connecticut.
Vil nan Connecticut
Tèks ofisyèl etid la (Anglè)
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
- Yale University, New Haven
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Sep 28, 2026 · NCT07610369A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Yale School of Medicine - Yale Program for Psychedelic Science, New Haven
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Cromwell
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07065240A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Institute of Living, Hartford
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Sep 8, 2026 · NCT07076407PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
- Mood Institute, Milford
- Yale School of Medicine, New Haven
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06713616A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Yale University School of Medicine, New Haven
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 6, 2026 · NCT07412756E-Mindfulness Approaches for Living After Breast Cancer
- Stamford Hospital/Bennett Cancer Center, Stamford
Ap rekriteFaz 3
Laj 18 a 50 · Tout sèks · Mizajou Aug 4, 2026 · NCT06748222A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Ct Clinical Research Associates, Cromwell
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cromwell
- Neurocrine Clinical Site, Farmington
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
- Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine,, West Haven
Ap rekriteFaz 1Volontè an sante akeyi
Laj 21 a 65 · Tout sèks · Mizajou Jun 16, 2026 · NCT06671977Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life
- Yale University, New Haven
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou May 29, 2026 · NCT05810259The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
- VA Connecticut Healthcare System, West Haven
Ap rekriteFaz 2
Laj 21 a 65 · Tout sèks · Mizajou May 6, 2026 · NCT05786066Stress and Pain in People Living With HIV
- The Yale Stress Center, New Haven
Ap rekriteVolontè an sante akeyi
Laj 18 a 68 · Tout sèks · Mizajou Apr 27, 2026 · NCT06784908External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
- https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceL, Darien
Ap rekriteEtid obsèvasyon
Laj 18 a 44 · Fanm · Mizajou Apr 15, 2026 · NCT06788977Open-Label Psilocybin Study in Transdiagnostic Population
- Connecticut Mental Health Center - Yale School of Medicine, New Haven
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 11, 2026 · NCT06442423Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.